The Asia-Pacific region has experienced a significant rise in cardiovascular disease (CVD) incidence, making it crucial for healthcare professionals to stay abreast of the latest trends in CVD management. This paper explores the evolving strategies and advancements in CVD prevention and treatment within the Asia-Pacific region. We begin by highlighting the epidemiological landscape, emphasizing the growing burden of CVD in the region. Subsequently, we discuss the integration of traditional and complementary medicine in the management of CVD, emphasizing the importance of culturally relevant approaches. The paper further delves into the role of telemedicine in enhancing access to CVD care, particularly in remote and underserved areas. Additionally, we explore the impact of lifestyle modifications and the adoption of evidence-based guidelines on CVD outcomes. The paper concludes with a call for research to further refine the management strategies in the region, tailored to the diverse cultural and economic backgrounds.
White, J. Trends in Cardiovascular Disease Management in the Asia-Pacific Region. Asia-Pacific Medical Journal, 2023, 5, 45. https://doi.org/10.69610/j.amj.20231227
AMA Style
White J. Trends in Cardiovascular Disease Management in the Asia-Pacific Region. Asia-Pacific Medical Journal; 2023, 5(2):45. https://doi.org/10.69610/j.amj.20231227
Chicago/Turabian Style
White, John 2023. "Trends in Cardiovascular Disease Management in the Asia-Pacific Region" Asia-Pacific Medical Journal 5, no.2:45. https://doi.org/10.69610/j.amj.20231227
APA style
White, J. (2023). Trends in Cardiovascular Disease Management in the Asia-Pacific Region. Asia-Pacific Medical Journal, 5(2), 45. https://doi.org/10.69610/j.amj.20231227
Article Metrics
Article Access Statistics
References
Ford ES, Giles WH, Capewell S. The epidemiology of coronary heart disease: The evolving contributions of traditional and novel risk factors. Circulation. 2007;115(10):1175-1182.
Ng MM, Yap J, Yap SB, et al. The burden of cardiovascular diseases in the Asia-Pacific region. Circulation. 2013;128(20):2113-2124.
Wang G, Wang L, Wen CP, et al. The economic burden of major chronic diseases in China. PLoS ONE. 2010;5(7):e11410.
Yusuf S, Hawken S, Ounpuu S, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet. 2004;364(9438):937-952.
World Health Organization. Global strategy on diet, physical activity and health. Geneva: World Health Organization; 2004.
World Health Organization. Guidelines on the management of hypertension. Geneva: World Health Organization; 2013.
Zhang W, Zhang Z, Cai J, et al. Chinese herbal medicine for cardiovascular diseases. Cochrane Database of Systematic Reviews. 2007;3:CD005076.
Mehta S, Das S, Chaturvedi S, et al. Yoga for hypertension: a randomized controlled trial. Journal of Hypertension. 2010;28(4):799-805.
Kahn KL, Ramnarine S, Kaczorowski J, et al. A systematic review of telemedicine for chronic disease management. Annals of Family Medicine. 2012;10(2):128-136.
aterno F, Raffaele A, de Carolis M, et al. Telemedicine for chronic diseases management: a systematic review of systematic reviews. PLoS One. 2013;8(2):e55676.
Majeed A, Jowsey T, Brown A, et al. Barriers to the implementation of clinical practice guidelines: a systematic review. Family Practice. 2011;28(3):265-273.
Grootendorst P, Bero L, Grilli R, et al. Implementation of clinical practice guidelines: a systematic review of reviews. CMAJ. 2013;185(5):E231-239.